# Fidelity Disruptive Medicine Fund

Fidelity Disruptive Medicine Fund is a registered fund series of Fidelity Summer Street Trust (series S000067934). Net assets $43.2M as of 2023-05-31.

## Profile

- Series ID: S000067934
- Registrant: Fidelity Summer Street Trust
- LEI: 5493007XTIYCYSL2XN98
- Net assets: $43.2M
- Total assets: $43.7M
- As of: 2023-05-31

## Advisers

- [FMR Investment Management (UK) Limited (Subadvisor)](https://search.stillhousedata.com/firm/108273)
- [Fidelity Management & Research Company LLC (Advisor)](https://search.stillhousedata.com/firm/108281)
- [Fidelity Management & Research (Hong Kong) Limited (Subadvisor)](https://search.stillhousedata.com/firm/148045)
- [Fidelity Management & Research (Japan) Limited (Subadvisor)](https://search.stillhousedata.com/firm/148239)

## Top holdings (68 reported)

_Showing 15 of 68 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [BOSTON SCIENTIFIC CORP](https://search.stillhousedata.com/security/101137107) | — | $1.9M | 447.33% |
| [UNITEDHEALTH GROUP INC](https://search.stillhousedata.com/security/91324P102) | — | $1.7M | 400.84% |
| [HUMANA INC](https://search.stillhousedata.com/security/444859102) | — | $1.7M | 387.91% |
| [PENUMBRA INC](https://search.stillhousedata.com/security/70975L107) | — | $1.6M | 364.90% |
| [VERTEX PHARMACEUTICALS INC](https://search.stillhousedata.com/security/92532F100) | — | $1.6M | 362.76% |
| [LILLY (ELI) and CO](https://search.stillhousedata.com/security/532457108) | — | $1.5M | 355.59% |
| [INSULET CORP](https://search.stillhousedata.com/security/45784P101) | — | $1.5M | 338.75% |
| [DANAHER CORP](https://search.stillhousedata.com/security/235851102) | — | $1.4M | 319.96% |
| ROYALTY PHARMA PLC | — | $1.4M | 314.75% |
| [MASIMO CORP](https://search.stillhousedata.com/security/574795100) | — | $1.3M | 292.46% |
| [CENTENE CORP DEL](https://search.stillhousedata.com/security/15135B101) | — | $1.3M | 290.55% |
| [BRUKER CORP](https://search.stillhousedata.com/security/116794108) | — | $1.2M | 279.34% |
| [ARGENX SE](https://search.stillhousedata.com/security/04016X101) | — | $1.1M | 253.32% |
| [ALNYLAM PHARMACEUTICALS INC](https://search.stillhousedata.com/security/02043Q107) | — | $1.1M | 246.28% |
| [10X GENOMICS INC](https://search.stillhousedata.com/security/88025U109) | — | $992K | 229.60% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2023-05-31 | $43.2M |
| 2023-02-28 | $42.1M |
| 2022-11-30 | $48.6M |
| 2022-08-31 | $55.8M |
| 2022-05-31 | $52.3M |
| 2022-02-28 | $66.9M |
| 2021-11-30 | $80.3M |
| 2021-08-31 | $82.2M |

## More

- [Registrant: Fidelity Summer Street Trust](https://search.stillhousedata.com/registrant/225322)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000067934.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.